Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vittoria Biotherapeutics

Request full access

Focuses on expanding the applications for CAR-based therapeutics using Novel Cell Engineering Technologies

Philadelphia, United StatesFounded 2021Biotech & Life Sciences

About Vittoria Biotherapeutics

Vittoria Bio is a clinical-stage biotechnology company specializing in next-generation cell therapy and gene editing technologies. The company focuses on developing innovative treatments for oncology and autoimmune diseases, leveraging advanced gene editing techniques to enhance the efficacy and safety of cell therapies. Vittoria Bio serves the healthcare sector, particularly targeting unmet clinical needs in cancer and autoimmune disorders. The business model involves generating proof-of-concept clinical data for its lead programs, such as Viper 101, in a cost-effective manner to achieve rapid market penetration. Revenue is primarily derived from strategic partnerships, licensing agreements, and potential future sales of its proprietary therapies. The company operates in the highly competitive biotechnology market, collaborating with industry leaders like Metagenomi to stay at the forefront of technological advancements.

Source: Dealroom company data

At a glance

Status
Operational
Employees
13
Open positions
None listed
Dealroom signal
40.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Nov 2024 $0 — Agent Capital · Tellus BioVentures · Global BioAccess Fund · University of Pennsylvania ↗
EARLY VC✓Equity / VC Nov 2023 $15M $60M The Leukemia & Lymphoma Society · Tellus BioVentures · BioAdvance · Agent Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Vittoria Biotherapeutics website traffic

Latest recorded traffic for Vittoria Biotherapeutics is 2.8K monthly website visits, up 100% over the last three months. Vittoria Biotherapeutics's team grew 8.3% over the past year.

Latest monthly visits2.8K 3-month web change+100% 1-year team growth+8.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Vittoria Biotherapeutics in the Philadelphia ecosystem

Live from Dealroom

The Vittoria Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • Agent Capital
  • Tellus BioVentures
  • SV Health Investors

Series A7 investors entered at this stage

  • Valley Forge Investment
  • The Leukemia & Lymphoma Society
  • BioAdvance
  • University of Pennsylvania
  • NYBC Ventures
  • Global BioAccess Fund
  • Hatch Biofund Management
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vittoria Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vittoria Biotherapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.